Molecular Modelling Group

What do we do?

The Molecular Modelling group (MMG) studies mechanisms of molecular recognition, in particular protein-protein or protein-small ligand interactions. The group develops and employs molecular modelling techniques such as homology, molecular dynamics, docking and free energy simulations. Most efforts are concentrated on the development of new small molecule inhibitors of important targets for cancer therapy, as well as the design of proteins for T-cell engineering and cancer immunotherapy. The group also develops and maintains SwissDrugDesign, a platform of web tools dedicated to computer-aided drug design and runs the Protein Modelling Unit of the University of Lausanne.